In clinical use , CsA treatment inhibits 50-75% of CN activity in circulating leukocytes .
in clinical use , csa treatment inhibits 50-75% of cn activity in circulating leukocytes .
O O O O B-other_organic_compound O O O O B-protein_molecule O O B-cell_type I-cell_type O